Is Avai Bio, Inc. (AVAI) a Buy, Sell, or Hold?
Avai Bio, Inc.
OTC:AVAI
$0.184 USD
$0.0 (-1.08%)
- Volume
- 127.7K
- Average Volume
- 158.64K
- Market Capitalization
- $25.44M
- P/E Ratio
- -24.86
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.80
- Year Low
- $0.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.02
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Chris Winter |
| Industry | Software - Application |
| Sector | Technology |
| Current Symbol | AVAI |
| CUSIP | 89487B100 |
| CIK | 0001740797 |
| Web | https://avaibio.com |
| Phone | 866 533 0065 |
| Currency | USD |
| Employees | 1 |
| Country | LT |
Liquidity
| Debt-to-Equity Ratio | -0.56 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Cash Ratio | 0.02 |
Sales & Book Value
| Annual Sales | $- |
| Price / Sales | 0.00 |
| Cash Flow | -0.01 |
| Price / Cash Flow | -22.19 |
| Price / Book | -9.09 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.0089 |
| Trailing P/E Ratio | -24.86 |
| PEG Ratio | -0.37 |
| P/E Growth | -0.37 |
| Net Income | $-1.14M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | 47.64% |
| Return on Assets | -595.83% |
Financials Score
| AltmanZ Score | -79.55 |
| Piotroski Score | 1.00 |
| Working Capital | -2.91M |
| Total Assets | 172.91K |
| Ebit | -986.31K |
| Market Cap | 24.19M |
| Total Liabilities | 2.97M |
Poll Results
About Avai Bio, Inc. (OTC:AVAI) Stock
Avai Bio, Inc. operates as a holding company primarily focused on creating websites and mobile applications that offer users personalized and convenient experiences. Its business activities include providing IT consulting services and making artificial intelligence accessible to the general public. The company was established on November 6, 2017, and its main office is situated in Las Vegas, Nevada. ...
2026-05-20 08:45:00
LAS VEGAS, May 20, 2026 /PRNewswire/ -- Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, today announced—together with its joint venture partner and global biotechnology firm, Austrianova— a major milestone in the Company's path to clinical trials, the completion of a Master Cell Bank (MCB) of genetically modified cells that overexpress the α-Klotho protein. Now, the MCB will undergo comprehensive testing to confirm the absence of pathogenic viruses, as well as standard assays to verify the MCB is free from adventitious agents such as bacteria, mycoplasma, fungi, and yeast to meet regulatory expectations, including those set by the FDA.
2026-05-04 17:55:00
KELOWNA, BC / ACCESS Newswire / May 4, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU) ("Avant" or the "Company"), is pleased to announce the voting results from its annual general and special meeting (the "Meeting") of the shareholders of the Company (the "Shareholders") held on May 4, 2026. A total of 4,135,344 common shares were represented in person or by proxy at the Meeting, representing 27.85% of the total issued and outstanding common shares of the Company.
Avant Brands Announces its Annual General and Special Meeting
2026-04-15 16:30:00
KELOWNA, BC / ACCESS Newswire / April 15, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU) ("Avant" or the "Company"), is pleased to announce its upcoming annual general and special meeting (the "Meeting") of the shareholders of the Company (the "Shareholders") to be held on May 4, 2026. The notice of Meeting and the management information circular (the "Circular") is available to Shareholders on Avant's website as well as under Avant's profile on SEDAR+ at www.sedarplus.ca.
Frequently Asked Questions
-
What is the current Avai Bio, Inc. (AVAI) stock price?
-
Avai Bio, Inc.(OTC:AVAI) stock price is $0.184 in the last trading session. During the trading session, AVAI stock reached the peak price of $0.8 while $0.11 was the lowest point it dropped to. The percentage change in AVAI stock occurred in the recent session was --1.08% while the dollar amount for the price change in AVAI stock was -$-0.0.
-
AVAI's industry and sector of operation?
-
The OTC listed AVAI is part of Software - Application industry that operates in the broader Technology sector.
-
Who are the executives of AVAI?
-
Ivan Lunegov | President & Director
Chris Winter | Chief Executive Officer
Vitalis Racius | Chief Financial Officer, Director & Treasurer
Natalija Tunevic | Secretary
| -
How many employees does AVAI have?
-
Number of AVAI employees currently stands at 1. AVAI operates from Sv. Stepono g. 27D-2, Vilnius, NV 89108, LT.
-
Link for AVAI official website?
-
Official Website of AVAI is: https://avaibio.com
-
How do I contact AVAI?
-
AVAI could be contacted at phone #866 533 0065 and can also be accessed through its website. AVAI operates from Sv. Stepono g. 27D-2, Vilnius, NV 89108, LT.
-
How many shares of AVAI are traded daily?
-
The average number of AVAI shares traded daily for last 3 months was 158.64K.
-
What is the market cap of AVAI currently?
-
The market value of AVAI currently stands at $25.44M with its latest stock price at $0.184